AstraZeneca’s rare diseases unit Alexion has taken full control of Caelum Biosciences, gaining access to another rare disease drug, CAEL-101, which is a potential...
French chemical producer Arkema has announced it will build a new plant for bio-based polyamide 11 powder at Changsu, China, with start-up planned for 2023. The...
CureVac is withdrawing its first-generation Covid-19 vaccine candidate, CVnCoV, from the current approval process with the European Medicines Agency. In a statement, the...
US pharma giant Merck & Co has applied to the US Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of its oral antiviral drug molnupiravir...
US chemical giant Dow is pressing ahead with several projects aimed at delivering $3 billion in underlying EBITDA growth as it progresses toward carbon neutrality and...
Boehringer Ingelheim has inaugurated its Large Scale Cell Culture (LSCC) biopharmaceutical plant at Vienna, Austria. Built over a period of six years at a cost of more...
Dow has announced plans to build what it regards as the world’s first net-zero carbon emissions ethylene and derivatives complex at its Fort Saskatchewan site in Alberta...
Finnish chemicals company Kemira is evaluating a possible closure of its site in Pierre-Bénite, near Lyon in France. The site, which employs 13 people, produces ferric...
The World Health Organization (WHO) has recommended administering GlaxoSmithKline’s 33-year-old malaria vaccine to children across Africa in the hope of stalling the...
AstraZeneca has provided the US Food and Drug Administration (FDA) with encouraging study evidence that its antiviral cocktail candidate AZD7442 can prevent Covid-19...
